Working…
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of HS-196, an HSP90 Inhibitor-linked NIR Probe for Solid Malignancies

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03333031
Recruitment Status : Recruiting
First Posted : November 6, 2017
Last Update Posted : September 23, 2019
Sponsor:
Information provided by (Responsible Party):
Herbert Lyerly, Duke University

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 10, 2020
Estimated Study Completion Date : July 10, 2022